CEO: Neal S. Walker
Employees: 61
IPO: Oct 06, 2015
Prijs
€ 4,20
Verandering
▲ € 0,06
1,45%
Marktkapitalisatie
506,50M
Dagbereik
€ 4,01
€ 4,22
52-Weeksbereik
€ 1,05
€ 4,89
Volume
892.765
50D / 200D Gem.
€ 3,52
€ 2,49
Vorige Slotkoers
€ 4,14
Quick Summary
Belangrijkste Punten
Revenue grew 3,72% annually over 5 years — modest growth
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -47,11M
PEG of 0,08 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 61,91%
Capital efficient — spends only 1,42% of revenue on capex
Groei
Revenue Growth (5Y)
3,72%
Onder sectorgemiddelde (9,58%)
Revenue (1Y)-58,19%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-50,20%
Onder sectorgemiddelde (3,46%)
ROIC-54,45%
Net Margin-829,58%
Op. Margin-975,91%
Veiligheid
Debt / Equity
0,02
Onder sectorgemiddelde (0,23)
Current Ratio5,28
Interest Coverage0,00
Waardering
P/E Ratio
-7,80
Onder sectorgemiddelde (0,22)
Forward P/EN/A
P/B Ratio4,91
EV/EBITDAN/A
Dividend Yield0,00%
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (640 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -7,8 | 0,2 |
| P/B | 4,9 | 2,9 |
| ROE % | -50,2 | 3,5 |
| Net Margin % | -829,6 | 3,9 |
| Rev Growth 5Y % | 3,7 | 9,6 |
| D/E | 0,0 | 0,2 |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -58,19% | Revenue Growth (3Y) | -49,96% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 3,72% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 7,83M | Net Income (TTM) | -64,92M |
| ROE | -50,20% | ROA | -40,46% |
| Gross Margin | 73,28% | Operating Margin | -975,91% |
| Net Margin | -829,58% | Free Cash Flow (TTM) | -47,11M |
| ROIC | -54,45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 5,28 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -7,80 | Forward P/E | N/A |
| P/B Ratio | 4,91 | P/S Ratio | 64,72 |
| PEG Ratio | 0,08 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -9,30% | ||
| Market Cap | 506,50M | Enterprise Value | 488,66M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7,83M | 18,72M | 31,25M | 29,75M | 6,76M |
| Net Income | -64,92M | -132,07M | -88,48M | -86,91M | -90,87M |
| EPS (Diluted) | -0,53 | -1,71 | -1,27 | -1,33 | -1,60 |
| Gross Profit | 5,74M | 15,93M | 13,17M | 17,79M | 2,05M |
| Operating Income | -76,38M | -141,93M | -97,36M | -89,85M | -89,72M |
| EBITDA | -64,47M | -51,72M | -115,45M | -84,36M | -64,46M |
| R&D Expenses | 52,65M | 33,59M | 98,38M | 77,81M | 43,81M |
| SG&A Expenses | 21,97M | 22,20M | 31,10M | 25,13M | 23,62M |
| D&A | 454.000,0 | 807.000,0 | 863.000,0 | 797.000,0 | 923.000,0 |
| Interest Expense | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Income Tax | 0,0 | 0,0 | -367.000,0 | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 160,46M | 220,33M | 197,41M | 254,60M | 251,21M |
| Total Liabilities | 57,38M | 64,77M | 40,23M | 56,98M | 53,87M |
| Shareholders' Equity | 103,08M | 155,55M | 157,18M | 197,62M | 197,34M |
| Total Debt | 2,12M | 0,0 | 426.000,0 | 684.000,0 | 693.000,0 |
| Cash & Equivalents | 19,96M | 24,57M | 39,88M | 45,28M | 27,35M |
| Current Assets | 151,36M | 125,95M | 128,86M | 231,55M | 205,03M |
| Current Liabilities | 28,65M | 31,60M | 30,95M | 21,94M | 22,93M |